Nav: Home

First classification of severe asthma

September 28, 2015

Amsterdam, The Netherlands: Severe asthma can have a devastating effect on sufferers, affecting their ability to work or go to school and to lead normal lives. It is difficult to treat because it is not a single disease entity. Now, for the first time, a group of European researchers has succeeded in defining three distinct types of severe asthma by analysing sputum samples from a group of patients.

Presenting her team's results to the European Respiratory Society's International Congress 2015 today (29 September 2015), Ms Diane Lefaudeux, a research engineer at the European Institute of Systems Biology and Medicine, Lyon, France, will say that they have taken the first step towards understanding how the different categories of patients vary in terms of what is causing their severe asthma,and that in the long term this would enable the development of drugs tailored to each category, as well as help identify existing drugs that could be used to help a particular group of patients. "We knew that each new treatment does not work in all people with the disease, which is why we decided to undertake sputum 'handprinting' in 72 people across the severity of asthma, including smokers," she said.

The research was carried out by U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes), a public/private partnership, using information and samples from European adults and children in order to learn more about the different types of asthma. For their research on severe asthma, the scientists analysed patient sputum samples using gene expression measurements (transcriptomics), abundance of proteins (focused and non-focused proteomics), and measurements of abundance of certain lipids (focused lipidomics). "Each 'omic' type brings a different and complementary piece of information concerning the biology of asthma and severe asthma, leading to the combination of fingerprints which make up the handprint of disease," says Ms Lefaudeux.

Difficult-to-treat asthma affects about 5% of the 30 million European asthma sufferers, and of those probably about half a million suffer from severe asthma, say the researchers. "We presume that severe asthma develops in patients who already have asthma and therefore the question is: what drives the evolution? We now believe that there may be a number of causes, since we have found that severe asthma consists of a number of different phenotypes," says Ms Lefaudeux.

Asthma is diagnosed at present by evaluation of the patient's symptoms of cough, wheeze, and chest tightness, but there is no test that is 100% accurate. Severe asthma is defined according to the amount of treatment that the asthmatic patient is taking, usually in addition to the inhaled corticosteroids and long-acting beta-agonists (medications that relax the muscle of the airways) prescribed to all asthmatic patients. Severe asthmatics often take other medications, in addition to regular corticosteroid tablets (50% of the U-BIOPRED sample were taking prednisolone).

The researchers intend to follow up their work by linking their findings to the large amount of clinical data and additional 'omics' data types that has been collected by the clinical centres of U-BIOPRED. Further and deeper analyses and interpretation of these data will help to understand the underlying biology of the newly identified groups of severe asthma patients.

To date, gaps in knowledge about differences between groups of severe asthma patients have made it difficult to predict, in the early stages of drug development, how well a new medicine will work, and for which group. "We believe that our work, dividing severe asthmatics into meaningful categories, is the first step towards being able to provide each sufferer with optimal individualised treatment, the ultimate goal of personalised medicine," Ms Lefaudeux will conclude.
-end-
Notes to editors:
  • Abstract: The first U-BIOPRED sputum handprint of severe asthma
  • Session: Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
  • Date and time: Tuesday 29, September, 10.45-12.45
  • Room: 5.1
The research received funding from the Innovative Medicines Initiative, a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). U-BIOPRED is a collaboration between academia, hospitals, patient groups, pharmaceutical companies, and small - medium enterprises.

There are a number of other abstracts linked to the U-BIOPRED project at the ERS Congress. Find out more on the U-BIOPRED website: http://www.europeanlung.org/en/projects-and-research/projects/u-biopred/news-and-events/news/u-biopred%E2%80%99s-results-will-be-showcased-at-ers-congress-2015

European Lung Foundation

Related Asthma Articles:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.
Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.
Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.
New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.
Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.
Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.
Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.
Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.
Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.
What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.
More Asthma News and Asthma Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.